VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1004412
Sex: F
Age:
State: GA

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Next day after the shot i feel a pain under my left arm. Days later the pain increase and i think is lymphoma; Next day after the shot i feel a pain under my left arm. Days later the pain increase and i think is lymphoma; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EL1283, expiry: unknown), via an unspecified route of administration in the left arm on 15Jan2021 07:00 at a single dose for COVID-19 immunization. The patient has no medical history and no known allergies. The patient has no Covid prior to vaccination. The patient's concomitant medications were not reported. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient mentioned that the next day after the shot (16Jan2021 at 05:30), the patient feel a pain under her left arm; days later, the pain increased, and she thinks it is lymphoma. The patient was not tested for Covid post vaccination. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 1004413
Sex: F
Age:
State: NY

Vax Date: 01/19/2021
Onset Date: 01/22/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: have two discoloration in my right thumb one black long line and one red line side by side around 1 and a half inches long and behind it is a circular black and discoloration; This is a spontaneous report from a contactable other hcp. A 68-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number= EL3247), via an unspecified route of administration on the right arm on 19Jan2021 12:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included hypertension, supraventricular tachycardia and hearing loss from an unknown date and unknown if ongoing. Concomitant medication included amlodipine (AMLODIPINE) and metoprolol tartrate (METOPROLOL TARTRATE). On 22Jan2021 05:00 AM, the patient stated, "I have two discoloration in my right thumb one black long line and one red line side by side around 1 and a half inches long and behind it is a circular black and discoloration." No treatment was received for the events. The outcome of the event was not recovered.

Other Meds: AMLODIPINE; METOPROLOL TARTRATE

Current Illness:

ID: 1004414
Sex: M
Age:
State: NC

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Minor soreness at injection site. Lasted about 48 hours; Minor sweats day of vaccination. Lasted 5 hours; This is a spontaneous report from a contactable consumer (patient). A 49-years-old male patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 19Jan2021 09:00 at SINGLE DOSE on Arm Left for covid-19 immunisation. The patient medical history was not reported. No covid prior vaccination. No other vaccine in four weeks. Known allergies: No. Had other medications in two weeks. The patient experienced minor soreness at injection site. lasted about 48 hours since on 19Jan2021 with outcome of recovered on 21Jan2021, minor sweats day of vaccination. lasted 5 hours on 19Jan2021 with outcome of recovered in Jan2021. No treatment received. No covid tested post vaccination.

Other Meds:

Current Illness:

ID: 1004415
Sex: M
Age:
State: NY

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: soreness in his arm; This is a spontaneous report from a contactable consumer. An adult male patient received first single dose of BNT162B2 (Pfizer/BioNTech, Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration on Jan2021 for COVID-19 immunization. The patient had no relevant medical history. The patient did not have covid prior vaccination. The patient's concomitant medications were not reported. The patient reported after his first shot he had soreness in his arm (onset date: Jan2021). The patient was not covid tested post vaccination. The outcome of the event was unknown. Information on the lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1004416
Sex: F
Age:
State: SC

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: administration date= 04Jan2021/Other vaccine same date vaccine date=21Jan2021; Lightheaded/Dizzy; vomiting; This is a spontaneous report from a contactable other HCP. This 24-year-old female other HCP (no pregnant) received 2nd dose of BNT162B2 (lot number=EL3249) on 21Jan2021 at single dose on Left Arm for covid-19 immunization. Medical history was Total colonic Hirschsprung's disease, POTS, asthma, chronic migraines, recurrent pneumonia, GERD. Historical Vaccine was 1st dose of BNT162B2 (Lot number= EL1284 on 04Jan2021 09:30 AM on Left arm). Known allergies: Erythromycin, azithromycin (Z-PACK), metoclopramide (REGLAND), diphenhydramine hydrochloride (BENADRYL). Concomitant drug included topiramate (TOPAMAX), esomeprazole sodium (NEXIUM), famotidine (PEPCID), ondansetron (ZOFRAN), budesonide/formoterol fumarate (SYMBICORT). No other vaccine in four weeks. Patient experienced Lightheaded, dizzy, vomiting on 21Jan2021 11:15 PM with outcome was recovered. No treatment. No Covid prior vaccination. No covid tested post vaccination. No follow-up attempts possible. No further information expected.

Other Meds: TOPAMAX; NEXIUM; PEPCID; ZOFRAN; SYMBICORT

Current Illness:

ID: 1004417
Sex: M
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe diarrhea; This is a spontaneous report from a contactable consumer (patient's wife). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Reporter was to report a possible side effect. The patient experienced severe diarrhea in Jan2021. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1004418
Sex: F
Age:
State: NJ

Vax Date: 01/20/2021
Onset Date: 01/01/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; muscle ache; joint pain; sweat; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received second single dose of BNT162B2 (Solution for injection, lot number: EL3247, exp date not reported), via an unspecified route of administration (Anatomical location: Arm Right)on 20Jan2021 15:00 for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination and was not pregnant at the time of reporting. The patient previously took first single dose of BNT162B2 (lot number unknown) on an unspecified date for COVID-19 immunization. The patient experienced chills, muscle ache, joint pain, and sweat on Jan2021. The events were considered as non-serious. The outcome of events was unknown.

Other Meds:

Current Illness:

ID: 1004419
Sex: F
Age:
State: TX

Vax Date: 01/02/2021
Onset Date: 01/08/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Date: 20210111; Test Name: Covid-19; Test Result: Positive

Allergies:

Symptoms: developed COVID symptoms/diagnosed positive in Covid19/ tested positive for Covid; developed COVID symptoms/diagnosed positive in Covid19/ tested positive for Covid; This is a spontaneous report from a contactable nurse (patient). This nurse reported same event for two patients (patient and her husband), this is the first of two reports, the report for patient herself. A 69-year-old female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number EL0142, expiration date unknown), via an unspecified route of administration in arm (reported as deltoid) on 02Jan2021 at single dose for COVID-19 immunization. The patient denied relevant medical history. Concomitant medications were not reported. The patient got her first dose on 02Jan2021, and on 08Jan2021 developed COVID symptoms. On 11Jan2021, she tested positive for COVID-19/diagnosed positive in COVID-19. The reporter nurse think they were exposed sometime at that pharmacy, she mean there was a lot of people in the line. Tomorrow (unspecified) was supposed to be second dose and his family physician didn't know if he should get that second dose. The outcome of events was unknown.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported drug ineffective and COVID-19 cannot be ruled out.,Linked Report(s) : US-PFIZER INC-2021064940 Same reporter/drug/event, different patient

Other Meds:

Current Illness:

ID: 1004420
Sex: F
Age:
State: PA

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Aching joints; severe headache; blotchy skin on arms; This is a spontaneous report from a contactable other hcp reported for herself. A 49-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL1282), via an unspecified route of administration on the left arm on 21Jan2021 11:15 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported. Concomitant medication included sertraline (SERTRALINE). The patient previously took the first dose of bnt162b2 (lot number: EL0142) for covid-19 immunization on 31Dec2020 and diflucan and experienced drug hypersensitivity. The patient experienced aching joints, severe headache, blotchy skin on arms on 22Jan2021 04:00 AM . The patient underwent lab tests and procedures which included sars-cov-1 test: negative on 22Jan2021. No treatment was received for the events. The outcome of the events was not recovered.

Other Meds: SERTRALINE

Current Illness:

ID: 1004422
Sex: M
Age:
State: KY

Vax Date: 12/15/2020
Onset Date: 01/05/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; Sweating for approx 12-24 hours; This is a spontaneous report from a contactable healthcare professional (patient himself). A 28-year-old male patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EH9899, expiry date: Mar2021), intramuscular in the left arm on 15Dec2020 14:45 at a single dose for COVID-19 immunization. The patient was vaccinated in a hospital facility. Medical history included Type II diabetic, irregular heartbeat (Sinus Arrhythmia), and gout. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included atenolol. The patient previously had allergy with lisinopril. On 05Jan2021 23:30, the patient experienced headache and sweating for approximately 12-24 hours. The events resulted in doctor or other healthcare professional office/clinic visit. The patient received prednisone and Benadryl as treatment. The outcome of the events was recovering. The case was considered non-serious. No follow-up attempts are possible. No further information is expected.

Other Meds: ATENOLOL

Current Illness:

ID: 1004423
Sex: F
Age:
State: MO

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: body temperature; Result Unstructured Data: Test Result:102.8 Fahrenheit

Allergies:

Symptoms: 102.8 F fever; aches in muscles and joints; aches in muscles and joints; chills; headache; This is a spontaneous report from a contactable consumer, the patient. This 51-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: EL9262), first dose, via an unspecified route of administration in the left arm on 21Jan2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 vaccination. Medical history included migraine from an unknown date and unknown if ongoing, cow's milk protein allergy from an unknown date and unknown if ongoing, lactose allergy from an unknown date and unknown if ongoing, peppermint allergy from an unknown date and unknown if ongoing and Penicillin allergy from an unknown date and unknown if ongoing. Concomitant medication included butalbital (BUTALBITAL), zolmitriptan (ZOMIG), fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]), benzonatate (BENZONATATE) and levocetirizine dihydrochloride (XYZAL). The patient previously took bactrim and experienced drug hypersensitivity, ultram er and experienced drug hypersensitivity. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. On 21Jan2021 at 04:00, the patient experienced 102.8 degree Fahrenheit fever, aches in muscle and joints, headache and chills. No therapeutic measures were taken as a result of the events. The clinical outcome of the 102.8 degree Fahrenheit fever, aches in muscle and joints, headache and chills was resolving. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: BUTALBITAL; ZOMIG; FLONASE [FLUTICASONE PROPIONATE]; BENZONATATE; XYZAL

Current Illness:

ID: 1004424
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: side effects he had: nausea; side effects he had: "warm"; side effects he had: "feel lousy"; This is a spontaneous report from a contactable consumer (patient). A 31-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number and expiration date unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was asking if he could take Tylenol or Motrin to treat his side effects after receiving his 1st dose of the vaccine. The side effects he had included: nausea, "warm", and "feel lousy". The reporter said that the vaccination location told him that most people experience the symptoms that he was feeling. The reporter said he already spoke with another nurse. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1004425
Sex: F
Age:
State: NC

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore arm; fatigue; This is a spontaneous report from a contactable consumer reported for herself. A 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL3247), via an unspecified route of administration on the left arm on 16Jan2021 07:00 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported. Concomitant medication included sertraline hydrochloride (ZOLOFT), probiotics (PROBIOTICS), lecithin (LECITHIN) and multivitamin. The patient experienced sore arm and fatigue on 16Jan2021 18:00. No treatment was received for the events. The outcome of the events was recovered on an unspecified date.

Other Meds: ZOLOFT; PROBIOTICS; LECITHIN

Current Illness:

ID: 1004426
Sex: M
Age:
State: NY

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: temperature; Result Unstructured Data: Test Result:99.1 Fahrenheit; Comments: 14:15

Allergies:

Symptoms: Low grade temperature (99.1 degree F); Tiredness; This is a spontaneous report from a contactable healthcare professional (patient himself). A 26-year-old male patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL3247), via an unspecified route of administration in the left arm on 21Jan2021 15:45 at single dose for covid-19 immunization. The patient was vaccinated in the workplace clinic. The patient's medical history and concomitant medications were not reported. The patient has no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Jan2021 14:15, the patient experienced low grade temperature (99.1 degree F) and tiredness. No treatment was received for the adverse events. The outcome of the events was recovered on 22Jan2021 (time unknown). The case has been considered non-serious.

Other Meds:

Current Illness:

ID: 1004427
Sex: F
Age:
State: MA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: nausea; body aches; headache; fatigue; tingling in both hands (and fingers); crushing depression; This is a spontaneous report from a contactable healthcare professional. A 55-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration at the left arm on 19Jan2021 13:45 at single dose for COVID-19 immunisation. Medical history included osteoarthritis, restless legs syndrome, rubber sensitivity (latex allergies), and COVID-19. The patient was diagnosed with COVID-19 prior to vaccination. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication included ropinirole. On 19Jan2021 14:15, the patient experienced nausea, body aches, headache, fatigue, tingling in both hands (and fingers) and crushing depression. No treatment was received for the adverse events. Clinical outcome of the events was recovered on an unspecified date. Information on the lot/batch number has been requested.

Other Meds: ROPINIROLE

Current Illness:

ID: 1004428
Sex: F
Age:
State:

Vax Date: 01/18/2021
Onset Date:
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: experienced urinary tract infection; Medical history included multiple sclerosis, immune suppressants a month ago for multiple sclerosis; Medical history included multiple sclerosis, immune suppressants a month ago for multiple sclerosis; This is a spontaneous report from a non-contactable consumer reported for herself. This female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number unknown) via an unspecified route of administration on 18Jan2021 as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. Concomitant medications were not reported. The patient previously took immune suppressants a month ago for multiple sclerosis. The patient reported that she had first dose of the COVID-19 vaccine on 18Jan2021, and she had some reactions similar to those she usually got when she took steroids. The patient experienced urinary tract infection. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1004429
Sex: M
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: MRI; Result Unstructured Data: Test Result:Unknown Results

Allergies:

Symptoms: Sharp pain in his heart; Wild palpitations; Extreme erratic heart beat; wiped out; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL1248), via an unspecified route of administration on 11Jan2021 at single dose at left arm for covid-19 immunisation. Medical history included Lyme's disease from 09Jun2018 and ongoing, ongoing heart issues, cholesterol lowering and swelling (He was on a water pill for swelling). Concomitant medication included atenolol for heart medication, pitavastatin calcium (LIVALO) for cholesterol lowering. Patient was calling to report a negative reaction with Covid-19 vaccine. Four hours after the injection he laid down in bed and was relaxing on 11Jan2021. He felt a sharp pain in his heart. It was about 1 to 1.5 inches to the right of his nipple. It felt like a knife being jabbed in his chest. This only happened once. His heart was having wild palpitations. He had an extreme erratic heart beat lasting 30-40 seconds. It was terrifying. He had a lot of irregular heart beats for 3-4 days. He was wiped out and unable to get out of bed for 5 days. He had an MRI on 21Jan2021. He was waiting on the results. The erratic heart beats come and go. They were not as pronounced as the first week. He was not getting the second dose. He had not had a flu shot for the last 3 years. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. No history of all previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of the Pfizer suspect. Outcome of event sharp pain in his heart recovered with sequel on 11Jan2021, wild palpitations was recovered in Jan2021, extreme erratic heart beat was recovering, wiped out was recovered with sequel on 16Jan2021. The report was considered as non-serious.

Other Meds: ATENOLOL; LIVALO

Current Illness: Heart disorder; Lyme's disease

ID: 1004430
Sex: F
Age:
State: CA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; This is a spontaneous report from a contactable consumer. An 89-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 19Jan2021 at single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD), glucose tolerance impaired (pre-diabetic), lung cancer, and lymphoma. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a nursing home/senior living facility. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. The patient experienced headache on 19Jan2021. No treatment was received for the adverse event. Clinical outcome of event was recovered on an unspecified date. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1004431
Sex: F
Age:
State: NC

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore at injection site; This is a spontaneous report from a contactable consumer (patient herself). A 66-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration in the left arm on 06Jan2021 15:30 at a single dose for COVID-19 immunization. The patient was vaccinated in a doctor's office/urgent care. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient is not pregnant at the time of vaccination. On 06Jan2021 16:00, the patient experienced sore at injection site with outcome of recovered on unspecified date in Jan2021. The patient did not receive treatment for the reported event. The case was considered non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1004432
Sex: F
Age:
State: MO

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fainted; Dizziness; Heart racing; This is a spontaneous report from a contactable consumer reported for herself. A 22-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Jan2021 15:45 at single dose in left arm for COVID-19 immunisation. The patient medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. Concomitant medication included lisdexamfetamine mesilate (VYVANSE), escitalopram oxalate (LEXAPRO), spironolactone and Birth control product. The patient experienced fainted morning after 1st dose with dizziness and heart racing on 22Jan2021 06:45 - had to go to ER. The patient received anti-nausea and heart monitor as treatment for the adverse event. Events outcome was unknown. Information on the lot/batch number has been requested.

Other Meds: VYVANSE; LEXAPRO; SPIRONOLACTONE

Current Illness:

ID: 1004433
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: bilateral leg paralysis; nauseous; hardly walk; muscles were so tight/jaws felt locked, like a tightness; numbness on the left side of [her] face, right under the eye; temporary rash she had on the left side of her face, under her cheek; toes crowded back; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received the first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 at single dose "on the left side" for covid-19 immunisation. The patient medical history and concomitant medications were not reported. She stated feeling nauseous right after the shot and mentioned not eating breakfast. She described having bilateral leg paralysis which she also qualified as locked to the point where she could hardly walk. She added that her leg muscles were so tight that her toes crowded back. She then explained having numbness on the left side of her face, right under the eye and that her jaws felt locked, like a tightness. She specified she didn't know if she really felt tightness in her jaws because of the intensity of her bilateral leg paralysis. She then described a temporary rash she had on the left side of her face, under her cheek. She said her experience occurred two hours post injection on 21Jan2021 and was resolved in Jan2021 after taking a muscle relaxer. She asked if shellfish is in the vaccine. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1004434
Sex: M
Age:
State: NE

Vax Date:
Onset Date:
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: he is disabled and has congestive heart failure.; This is a spontaneous report from a contactable consumer (patient). A male patient (age: 74, unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient stated he was disabled and had congestive heart failure. The patient stated that he read the CDC had decided to only give one shot, everything he read on the website saying designed for 2 doses of the covid 19 vaccine. He received his shot and they might not be able to give 2 doses. The outcome of event was unknown. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1004435
Sex: F
Age:
State: MI

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: nausea; chills; her lips became really chapped; This is a spontaneous report from a non-contactable consumer. This female consumer (patient) with unspecified age reported for herself that she received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 at single dose for COVID-19 immunization at hospital. The patient medical history and concomitant medications were not reported. Patient did not experience any problems there after waiting 15 minutes. When she got home, she started to have chills and her lips became really chapped on 21Jan2021. This morning 22Jan2021, she's having some chills and nausea. She was taking diphenhydramine (BENADRYL). Outcome of events was unknown. No follow-up attempts are possible. Information about batch/ lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1004436
Sex: F
Age:
State: WA

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: diarrhea; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received bnt162b2 (BNT162B2, lot number EL3302) , via an unspecified route of administration on 21Jan2021 12:00 at single dose on left arm for covid-19 immunisation. Medical history included none. Concomitant medication included citalopram hydrobromide (CELEXA), zolpidem tartrate (AMBIEN). No other vaccine in four weeks. The patient experienced diarrhea on 22Jan2021 08:00. No treatment received. No covid prior vaccination, no covid tested post vaccination, no known allergies. The outcome of the event was not recovered.

Other Meds: CELEXA [CITALOPRAM HYDROBROMIDE]; AMBIEN

Current Illness:

ID: 1004437
Sex: F
Age:
State: WI

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: She passed out.; This is a spontaneous report from a contactable consumer (parent). A 17-year-old female patient (daughter) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number= EL1284) on 22Jan2021 11:45 AM at left arm at single dose for COVID-19 immunisation. Medical history and concomitant medications were none. No known allergies. Patient was not pregnant. Patient did not have COVID prior vaccination, and did not have other vaccine in four weeks, did not other medications in two weeks. The patient experienced passed out on 22Jan2021 12:00 PM. Treatment included they had her lay on the ground with her knees up and cold compresses. Patient did not test COVID post vaccination. The outcome of event was recovering.

Other Meds:

Current Illness:

ID: 1004438
Sex: M
Age:
State: MO

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: bad headache; chills; This is a spontaneous report from a contactable consumer. This consumer reported for a 26-year-old male patient who received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number/Exp. date unknown) on 21Jan2021 at 12:30 PM via unknown route of administration at single dose (at the age of 26 years old) for covid-19 immunisation. Relevant medical history and concomitant medication were not provided. It was unknown if patientrecived any other vaccines within 4 weeks prior to the COVID vaccine. On unknown date, the patient reported that he got a bad headache at night which has become cyclical. He also got chills every once in a while. The events outcome was unknown. It was unknown if patient received any treatment for events. Since the vaccination, it was unknown if the patient has been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1004439
Sex: F
Age:
State: NC

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: cancerous cells; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received her first dose of PFIZER-BIONTECH COVID-19 VACCINE on 14Jan2021. She had a surgical procedure Wednesday 20Jan2021, and was prescribed a cephalosporin antibiotic for 7 days post-procedure precautionary remove cancerous cells somebody suggested, it was a doctor. She was asking if there are any drug interactions between the antibiotic and the vaccine. Also, a doctor suggested that she take a dose of ibuprofen prior to her second vaccine dose on 05Feb2021. It was also reported the patient had a little surgical procedure with the Dermatologist this week (in Jan2021) and she just wanted to know if the antibiotic, Cefadroxil, has any contraindications that would compromise her vaccine. She had to take it for 7 days and it was to prevent bacterial infections. It was a procedure on her leg and she was also given an antibiotic cream also to help. The patient felt it was more important for her with having this vaccine and that was why she was calling. The event outcome was unknown. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 1004440
Sex: F
Age:
State: NC

Vax Date: 01/14/2021
Onset Date: 01/18/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Silver dollar sized swelling and redness around the injection site for 4 days; Silver dollar sized swelling and redness around the injection site for 4 days; Silver dollar sized swelling and redness around the injection site for 4 days. After 4 days the redness subsided but a knot remains under the skins surface with heat to the touch and itching; Silver dollar sized swelling and redness around the injection site for 4 days. After 4 days the redness subsided but a knot remains under the skins surface with heat to the touch and itching; Silver dollar sized swelling and redness around the injection site for 4 days. After 4 days the redness subsided but a knot remains under the skins surface with heat to the touch and itching; This is a spontaneous report from a contactable Other Health Professional (patient). A 32-years-old female patient received first dose bnt162b2 (BNT162B2, lot: EL3247), intramuscular on 14Jan2021 11:15 at SINGLE DOSE on Arm Left for covid-19 immunisation. The patient medical history was not reported. Pregnant: No. No other vaccine in four weeks. The patient's concomitant medications were none. The patient experienced Adverse event: Silver dollar sized swelling and redness around the injection site for 4 days. After 4 days the redness subsided but a knot remains under the skins surface with heat to the touch and itching since 18Jan2021. The event outcome of redness around the injection site was recovered on 22Jan2021, outcome of other events were not recovered. No treatment received.

Other Meds:

Current Illness:

ID: 1004441
Sex: F
Age:
State: NY

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Date: 20210105; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Head hurting - constant achiness; received other vaccine on 20Jan2021 on the left arm; This is a spontaneous report from a contactable consumer (patient). This 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Jan2021 10:00 at single dose on the left arm for COVID-19 immunization. The patient medical history included allergies: Milk. Patient took migraine medications in two weeks. Facility type vaccine was hospital. Patient was not pregnant. The patient received other vaccine on 20Jan2021 on the left arm. The patient experienced head hurting - constant achiness on 20Jan2021 16:00. The patient underwent lab tests and procedures which included Nasal Swab: Negative on 05Jan2021. COVID tested post vaccination. No treatment received. Outcome of the event head hurting - constant achiness was not recovered. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1004442
Sex: F
Age:
State: MI

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Person indicated that they felt lethargic and had a headache.; Person indicated that they felt lethargic and had a headache.; This is a spontaneous report from a non-contactable consumer (patient). A 34-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, number: EC0142), via an unspecified route of administration on 20Jan2021 at single dose in arm left for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not have COVID prior vaccination. The patient previously received the first dose of BNT162B2 (lot number: EC 1284) in Left arm on 30Dec2020 for COVID-19 immunisation. The patient indicated that they felt lethargic and had a headache on 21Jan2021. The patient was not pregnant at the time of vaccination. COVID was not tested post vaccination. There was no treatment received for the event. Patient was recovered on an unspecified date in Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1004443
Sex: M
Age:
State: AZ

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Scratchy throat; Sinus; Head cold symptoms; He experienced drainage and flowing; His total left arm, where he got the vaccine, was sore all the way down; He felt light headed; Blurry vision; This is a spontaneous report from a contactable consumer (patient). This male patient of unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number/Exp. date unknown) on 18Jan2021 via unknown route of administration at single dose for covid-19 immunisation. Relevant medical history and concomitant medication were not provided. The patient reported that he received the covid vaccine on Monday, 18Jan2021, at which point he felt light-headed and blurry vision. He was kept for 30 minutes until it subsided. On Tuesday, 19Jan2021, his total left arm, where he got the vaccine, was sore all the way down. On Wednesday, 20Jan2021, he experienced drainage and flowing for which he took Benadryl which helped overnight. Yesterday, 21Jan2021 he reported heavy drainage, sinus or head cold symptoms. Today, 22Jan2021, he reported a scratchy throat. The outcome for events light-headed and blurry vision was recovered. The outcome for other events was unknown. The patient inquired as to what to do about his side effects after receiving the first dose of Covid-19 vaccine. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1004444
Sex: F
Age:
State:

Vax Date: 01/18/2021
Onset Date: 01/01/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Diarrhea; headache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose bnt162b2 (Pfizer-Biontech covid-19 vaccine), via an unspecified route of administration on 18Jan2021 in the afternoon at SINGLE DOSE for covid-19 immunisation. Medical history included Pulmonary fibrosis, lung infection. Concomitant medication included azithromycin (AZITHROMYCIN) on Mondays, Wednesdays and Fridays to Preventative for lung infection due to Pulmonary fibrosis, ibuprofen (IBUPROFEN) for Pulmonary fibrosis and other problems, had not taken any Ibuprofen since 16Jan2021. The patient had not had any symptoms other than a headache, so she is not sure if this was because of the vaccine or not; diarrhea on 20Jan2021. This consumer wanted to know how long before and after should get the Pfizer COVID-19 Vaccine shot do you have to stop taking Ibuprofen. She has Pulmonary fibrosis and other problems that she takes Ibuprofen for. She got the first dose of Pfizer COVID-19 Vaccine 18Jan2021. They did not tell her she would be getting the Pfizer COVID-19 Vaccine until the night before: 17Jan2021. She has not taken any Ibuprofen since Saturday night: 16Jan2021. She also mentioned that she had Diarrhea for 2 days in a row on Wednesday 20Jan2021 and Thursday 21Jan2021; Diarrhea is not too unusual for her because she takes Azithromycin 1 tablet 3 days/week continuously as preventative for lung infection due to her pulmonary fibrosis; she usually will get diarrhea on the day she takes the Azithromycin, but not on the days she does not-so the 2 days in a row of diarrhea she had 20Jan2021- 21Jan2021 she wanted to know if could be a possible side effect of the Pfizer COVID-19 Vaccine. The event outcome was unknown.

Other Meds: AZITHROMYCIN; IBUPROFEN

Current Illness:

ID: 1004445
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Name: covid-19; Test Result: Positive

Allergies:

Symptoms: COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable Pharmacist. A healthcare worker of unspecified age and gender received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient tested positive for covid-19 on an unspecified date with outcome of unknown. Information about Lot/Batch has been requested.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported drug ineffective and COVID-19 cannot be ruled out.

Other Meds:

Current Illness:

ID: 1004446
Sex: F
Age:
State: CT

Vax Date: 01/21/2021
Onset Date: 01/01/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Muscle pain; fatigue; This is a spontaneous report from a contactable consumer who is reporting for herself. A 26-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EL3247), via an unspecified route of administration left arm single dose on 21Jan2021 12:30 for covid-19 immunisation. No other vaccine was received in four weeks. The patient medical history was not reported. There were no concomitant medications. The patient experienced muscle pain on Jan2021, fatigue on Jan2021. No treatment received. The outcome was not recovered

Other Meds:

Current Illness:

ID: 1004447
Sex: F
Age:
State:

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Night sweats; This is a spontaneous report from a non-contactable consumer reporting for herself. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# unknown), via an unspecified route of administration single dose on 12Jan2021 for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced night sweats on 13Jan2021. The outcome was unknown No follow-up attempts are possible. Information on batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1004448
Sex: F
Age:
State: TN

Vax Date: 01/22/2021
Onset Date: 01/01/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Diarrhea; This is a spontaneous report from a contactable consumer (patient's husband). A 77-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated patient received the first dose of the COVID 19 vaccine and now has severe diarrhea on an unspecified date in Jan2021. The reporter stated the patient hasn't been able to leave the bedroom for two hours and he gave the patient a dose of magnesium. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1004449
Sex: M
Age:
State: MN

Vax Date: 01/09/2021
Onset Date: 01/11/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Guillain Barre syndrome/Symptoms started with 2 fingers tingling; This is a spontaneous report from a contactable nurse reporting for a patient. A 40-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK4176), via intramuscular on 09Jan2021 at single dose in left arm for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1685), via intramuscular on 22Dec2020 at single dose in left arm at the age of 39-year-old for COVID-19 immunization. Reported he was diagnosed with Guillain Barre syndrome. Symptoms started with 2 fingers tingling on 11Jan2021. Progressively increasing in severity. Now had numb fingers and toes. Initiating IV therapy on 22Jan2021. The adverse event result in Doctor or other healthcare professional office/clinic visit. The outcome of the event was unknown.; Sender's Comments: As an individual case report there is not enough evidence to establish a causal relationship with the suspect vaccine. Currently there is no clear biological plausibility between the vaccine use and the even onset. More information such as complete medical history and concomitant medications are needed for fully medical assessment. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1004450
Sex: F
Age:
State: CO

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Transient bilateral lower extremity neuropathy; periorbal and facial neuropathy; severe low back pain; tinnitus; This is a spontaneous report from a contactable other health professional (patient) reporting for herself. A 34-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number=EL3248), intramuscular at left arm on 20Jan2021 at single dose for covid-19 immunization. Medical history was none. No pregnant at the time of vaccination. The patient's concomitant medications were not reported. Historical vaccine included the first dose of BNT162B2 via intramuscular at left arm on 30Dec2020 for covid-19 immunization. Facility where the most recent COVID-19 vaccine administered was nursing home/senior living facility. The patient experienced transient bilateral lower extremity neuropathy, tinnitus, periorbital and facial neuropathy, severe low back pain on 20Jan2021 with outcome of unknown. No treatment was received for the adverse events. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1004451
Sex: M
Age:
State: MD

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Really bad headache/it has worsened; This is a spontaneous report from a contactable consumer (patient). A 50-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3247), via an unspecified route of administration on 21Jan2021 14:15 at single dose for COVID-19 immunization. Medical history reported as none. Concomitant medication included fluoxetine hydrochloride (FLUOXETINE). The patient had a small headache in the morning on 22Jan2021, he ignored it, but now it was getting worse. The outcome of event was not recovered. Information on the lot/batch number has been requested.

Other Meds: FLUOXETINE [FLUOXETINE HYDROCHLORIDE]

Current Illness:

ID: 1004452
Sex: M
Age:
State: NC

Vax Date: 01/19/2021
Onset Date: 01/21/2021
Rec V Date: 02/05/2021
Hospital: Y

Lab Data: Test Name: MRI; Result Unstructured Data: Test Result:cervical lymph node enlargement; Test Date: 202101; Test Name: pain of; Result Unstructured Data: Test Result:2-3 out of 10

Allergies:

Symptoms: severe left upper girdle pain in my shoulder and neck. Eventually I was admitted to the hospital for four days for pain management and a workup which yielded a diagnosis of inflammatory fasciitis; severe left upper girdle pain in my shoulder and neck. Eventually I was admitted to the hospital for four days for pain management and a workup which yielded a diagnosis of inflammatory fasciitis; severe left upper girdle pain in my shoulder and neck. Eventually I was admitted to the hospital for four days for pain management and a workup which yielded a diagnosis of inflammatory fasciitis; lymphadenopathy as an MRI showed cervical lymph node enlargement; This is a spontaneous report from a contactable physician. A male patient of an unspecified age started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE). The patient stated "Last Tuesday, I received my second vaccine. By Thursday I had severe left upper girdle pain in my shoulder and neck. Eventually I was admitted to the hospital for four days for pain management and a workup which yielded a diagnosis of inflammatory fasciitis. MRI showed cervical lymph node enlargement." The patient was hospitalized for severe left upper girdle pain in my shoulder and neck. eventually i was admitted to the hospital for four days for pain management and a workup which yielded a diagnosis of inflammatory fasciitis (fasciitis) for 4 days. The patient underwent lab tests and procedures which included magnetic resonance imaging: cervical lymph node enlargement, pain assessment: 2-3 out of 10 on Jan2021. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the reasonable temporal association, the Company cannot completely exclude the possible causality between the reported left upper girdle pain in shoulder and neck/ inflammatory fasciitis and the administration of the COVID-19 vaccine, BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.

Other Meds:

Current Illness:

ID: 1004453
Sex: F
Age:
State: NY

Vax Date: 01/14/2021
Onset Date: 01/20/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Name: Weight; Result Unstructured Data: Test Result:150lb-160lb

Allergies:

Symptoms: she was useless; diarrhea; vomiting; low grade fever; sore arm; Stomach cramps; didn't feel good; This is a spontaneous report from a contactable consumer (patient). The 54-years-old female patient (weight: 150lb-160lb) received first dose of bnt162b2 (BNT162B2, lot number: EL0142), via an unspecified route of administration in left arm on 14Jan2021 15:40 at SINGLE DOSE for covid-19 immunisation. Medical history included none. No Prior Vaccinations (within 4 weeks). Concomitant medication included levothyroxine sodium (SYNTHROID), omeprazole, calcium. On 20Jan2021 weds: "bad diarrhea", vomiting, low grade fever, sore arm (only the day after) and bad stomach cramps. Caller says, "if that's going to happen after 2nd dose- I wont take it". Caller referred to HCP for treatment of post vaccination side effects. She notes that at work on Wednesday she didn't feel good on 20Jan2021 and yesterday she was useless on 21Jan2021. She does feel better today thank goodness. No AE(s) require a visit to Emergency Room or Physician Office. The outcome of the events didn't feel good, she was useless, sore arm was unknown and was recovering for the rest events. No follow-up attempts possible. No further information expected.

Other Meds: SYNTHROID; OMEPRAZOLE; CALCIUM

Current Illness:

ID: 1004454
Sex: M
Age:
State: OK

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: It was hurting really bad this morning about where your heart is; felt like my chest was caving in for 5-6 hours; felt like a mule had kicked him in the chest; both sides of my ribs was hurting like I had been rodeoing/they were real sore/rib cage on both sides hurt real bad; felt drugged; dizzy feeling/lightheaded; headache; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date in Jan2021 at single dose for COVID-19 immunization. The patient medical history included blood pressure (abnormal). Concomitant medications included 5 mg of a blood pressure pill and male enhancement stuff. The patient stated he went to the health department and they sent him somewhere else to get the shot on Wednesday (Jan2021). It was the first dose of the vaccine and he had a little headache that night (Wednesday) at about 20:00 and he took a couple of aspirin. Got up on 21Jan2021 morning both sides of his ribs was hurting like he had been rodeoing, they were real sore, also reported as his rib cage on both sides hurt real bad and about 6 hours later it wore off. Thursday (Jan2021) he felt drugged, dizzy feeling and lightheaded, around 11:00 it dissipated. On 22Jan2021 morning when he got up he felt like his chest was caving in for 5-6 hours (also reported as he felt like a mule had kicked him in the chest) but he went on out and did his thing and it was 5 hours like that. It was hurting really bad on 22Jan2021 morning about where his heart was. He didn't know if he was having a heart attack. His symptoms were gone he was 98-99% better than he was. It wore itself down through the morning hours. By 10:30-11:00 it was about 50% gone and by 13:00 it was gone. He didn't think it went away, it was kind of hiding back there. It made his wonder if he should take the second shot. He had never had no Corona. The problems came when he had the shot. He took 5 mg of a blood pressure pill and male enhancement stuff that his doctor did warn him to tell them he was on it if he ever go to the ER. His second shot was scheduled for 10Feb2021. Wanted to know if this was a side effect that made him feel bad and hurt half the day and by the afternoon it's gone. Wanted to be sure since he was to get the booster. Wanted to know is this normal and what to do. The outcome of the events of the event rib pain was recovered on 21Jan2021, of the events felt drugged & dizzy feeling/lightheaded was recovered in Jan2021, of the other events was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1004455
Sex: F
Age:
State: MO

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: Tests; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptoms: Passed out; Pulseless for 30 seconds; Feel dizzy and nauseous; Feel dizzy and nauseous; This is a spontaneous report from a contactable Other Health Professional (patient). A 25-year-old female (not pregnant at the time of vaccination) patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number and expiration date unknown since not available/provided to reporter at the time of report completion), via an unspecified route of administration at left arm on 22Jan2021 11:45 at single dose for COVID-19 immunization at a Nursing Home/Senior Living Facility. The patient's medical history included known allergies: Sulfa and poppy seed. No other known medical history/conditions. For concomitant medications, the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took amoxicillin, clarithromycin (BIAXIN) and cefaclor (CECLOR), and experienced drug allergy. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested for COVID-19 since the vaccination. After receiving the vaccine, the patient was sitting in the observation area for about 10 minutes when she started to feel dizzy and nauseous. She raised her hand up and called for the nurse to come over. She passed out. She was pulseless for 30 seconds and they had to begin giving her CPR chest compressions. She woke up lying on the ground and was taken to the emergency room (ER) where they ran tests to see how she was doing and for observation for several hours. The patient was "discharged" this afternoon and was doing better. The events result in emergency room/department or urgent care. Treatment was received for the events, ER observation and care, and CPR chest compressions. The patient underwent lab tests and procedures which included test on 22Jan2021: unknown results. The outcome of events at the time of last observation was recovering. The reporter's assessment of the events was non-serious, no results in death, no life threatening, not causing/prolonging hospitalization, no disabling/incapacitating, no congenital anomaly/birth defect. Information on the lot/batch number has been requested.; Sender's Comments: The reported passed out and pulseless for 30 seconds were likely related to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) due to temporal relationship. However, considering the clinical course and medical history, other cause(s)/confounding factors cannot be excluded. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1004456
Sex: F
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/01/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: blood pressure; Result Unstructured Data: Test Result:208/189; Test Date: 202101; Test Name: fever; Result Unstructured Data: Test Result:102 Fahrenheit; Comments: degrees

Allergies:

Symptoms: her blood pressure which was 208/189; really bad shakes a fever of 102 degrees; really bad shakes a fever of 102 degrees; This is a spontaneous report from a contactable other HCP(patient). A 46-year-old female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 15Jan2021 at single dose for covid-19 immunization. Medical history included COVID-19 in Nov2020/Dec2020. The patient's concomitant medications were not reported. 12 hours later the patient had really bad shakes a fever of 102 degrees and she checked her blood pressure which was 208/189. She went to the Emergency Room to get checked out and she was told that it was probably due to the vaccine. Patient wanted to know if she should receive the second dose of the vaccine since she had this type of reaction after the first dose. She had COVID-19 in Nov2020/Dec2020. She was told in the Emergency Room that since she had a previous COVID-19 infection that she would experience worse side effects from the first dose of the COVID-19 dose than the second dose. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on temporal association, a possible contributory role of BNT162B2 cannot be excluded for reported blood pressure increased. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1004457
Sex: M
Age:
State: NY

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; Fever; Fatigue; Nausea; This is a spontaneous report from a contactable physician (patient). A 41-year-old male patient received second dose of bnt162b2 (reported as: product=COVID 19, brand=Pfizer), batch/lot no. and expiration date not provided, via an unspecified route of administration (vaccination location: left arm) on 21Jan2021 09:30 at a single dose for covid-19 immunization. Medical history included sinus tachycardia and Pvc (premature ventricular contractions). He had no allergies to medications, food, or other products. Concomitant medication included atenolol. Historical vaccine included first dose of bnt162b2 (reported as: product=COVID 19, brand=Pfizer) for covid-19 immunization on 31Dec2020 09:15 AM. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The most recent COVID-19 vaccine was administered at a hospital. The patient experienced headache 24-36 hours, fever at 36 hours, fatigue, and nausea on 21Jan2021 05:00 PM. No treatment received for the adverse events. All events were assessed as non-serious (did not result to death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating, and no congenital anomaly/birth defect). Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering. Information on the lot/batch number has been requested.

Other Meds: ATENOLOL

Current Illness:

ID: 1004458
Sex: F
Age:
State: FL

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection site very sore; arm swollen; Feverish; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL8982), via an unspecified route of administration in the left arm, on 21Jan2021 at 10:15 (at the age of 65-years-old) at a single dose for COVID-19 immunization. Medical history included atrial fibrillation (AFIB), shellfish allergy, allergy to pain medications, cancer, diabetes, high blood pressure, and COVID-19. The patient was not pregnant at the time of vaccination. Concomitant medications, taken within two weeks of vaccination, included amlodipine (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), and esomeprazole magnesium (ESOMEPRA). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced arm swollen and feverish on 21Jan2021 at 19:30 and injection site very sore on 23Jan2021. The events were reported as non-serious. It was reported that the injection site was very sore on the third day. Therapeutic measures were taken as a result of the events, which included paracetamol (TYLENOL) and icing arm. The clinical outcome of injection site very sore, arm swollen, and feverish was not recovered.

Other Meds: AMLODIPINE; SPIRONOLACTONE; LEVOTHYROXINE; ESOMEPRA

Current Illness:

ID: 1004459
Sex: F
Age:
State: WI

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Date: 20210112; Test Name: body temperature; Result Unstructured Data: Test Result:moderate to extreme body temperate changes; Comments: 20:30

Allergies:

Symptoms: Moderate to Extreme headaches daily since injection; Extreme fatigue/tiredness/Overall feel vary tired; Moderate to Extreme body temperate changes throughout the day; This is a spontaneous report from a contactable healthcare professional (patient). A 26-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), first dose via an unspecified route of administration in the right arm on 12Jan2021 at 08:30 at single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. The patient had no medical history and no concomitant medications. The patient had no allergies to medications, food, or other products. The most recent COVID-19 vaccine was administered in a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had no other medications received within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and was not been tested for COVID-19 since the vaccination. The patient experienced moderate to extreme headaches daily since injection, extreme fatigue/tiredness and moderate to extreme body temperate changes throughout the day on 12Jan2021 at 20:30. Overall feel vary tired along with headaches since the injections. No treatment was received for the adverse events. The events were considered as non-serious as did not results in death, non-Life threatening, did not cause/prolong hospitalization, non-disabling/incapacitating and no congenital anomaly/birth defect. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1004460
Sex: F
Age:
State: MT

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore at injection site; Severe nausea; vomiting; diarrhea starting 6 hours after injection; This is a spontaneous report from a contactable nurse (patient). A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Pfizer brand; lot number: Ek3246), via an unspecified route of administration on 13Jan2021 10:15 on left arm at a single dose for COVID-19 immunization. Medical history included psoriasis, lymphocytic colitis and allergies to pistachios (anaphylaxis). The patient's concomitant medications were not reported. The patient experienced sore at injection site, severe nausea, vomiting and diarrhea starting 6 hours after injection (pending clarification); all on 13Jan2021 14:30 (as reported). Then the same symptoms starting 22Jan2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no treatment received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered was at the hospital. The report was non-serious. The outcome of the events was recovered with sequelae.

Other Meds:

Current Illness:

ID: 1004461
Sex: F
Age:
State: CO

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: Body temperature; Result Unstructured Data: Test Result:103.3 Fahrenheit; Comments: fever that climbed to 103.3F overnight

Allergies:

Symptoms: By 10am the day after vaccine the fever broke and I was just left with fatigue; 10 hours after vaccine I started with a fever that climbed to 103.3F overnight; This was joined by chills; This was joined by chills and body/joint discomfort as well as headache; body/joint discomfort; headache; This is a spontaneous report from a contactable other healthcare professional (patient). A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection lot number: EL8982), intramuscular at left arm on 21Jan2021, 08:15 at single dose for COVID-19 immunization. The patient's medical history included hypothyroidism, penicillins allergy and COVID-19 diagnosed on an unspecified date prior to vaccination. The patient's concomitant medications included levothyroxine, minerals nos, vitamins nos (PRENATAL VITAMIN), and riboflavin. The patient was not pregnant at the time of vaccination. The patient previously received the first dose of BNT162B2 (lot number: EK9231) on 30Dec2020, 12:30 PM at left arm for COVID-19 immunization. The patient has not been tested for COVID-19 since vaccination. On 21Jan2021 18:00 (10 hours after vaccine), the patient started with a fever that climbed to 103.3F overnight. This was joined by chills and body/joint discomfort as well as headache. By 10am the day after vaccine (22Jan2021), the fever broke and she was just left with fatigue. No treatment was given for the events. Facility where the most recent COVID-19 vaccine was administered was at the hospital. The outcome of the events were recovering. The events were non-serious.

Other Meds: LEVOTHYROXINE; PRENATAL VITAMIN; RIBOFLAVIN

Current Illness:

ID: 1004462
Sex: F
Age:
State: SC

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain in the arm of the injection; muscle pain; fatigue; This is a spontaneous report from a contactable nurse reporting for herself. A 64-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL3249), via an unspecified route of administration on the right arm on 22Jan2021 08:45 am at single dose for COVID-19 immunisation. Medical history included hyperthyroidism, BP elevation, hyperlipidaemia and allergies to chocolate, coconuts, pineapple, and red dye from an unknown date. Patient previously took codeine, statins, Diflucan, and experienced allergies. Concomitant medication included methimazole, dexlansoprazole (DEXILANT), amlodipine, ezetimibe (ZETIA), evolocumab (REPATHA) from unspecified date and indication. On 22Jan2021 at 08:45 pm, it was reported that the patient experienced pain in the arm of the injection, muscle pain, and fatigue. No treatment was received. The events were considered as non-serious and did not resulted in death, life threatening condition, prolonged hospitalization, disability, and congenital anomaly or birth defect. The patient was not diagnosed with COVID-19 prior to the vaccination and has not been tested for COVID-19 since vaccination. No other vaccines were received within the last 4 weeks prior to receiving the COVID-19 vaccination. The patient was reported to be not pregnant at the time of vaccination. The outcome of the events were not recovered.

Other Meds: METHIMAZOLE; DEXILANT; AMLODIPINE; ZETIA; REPATHA

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm